Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 3
2014 1
2015 2
2016 1
2017 2
2018 2
2019 3
2020 1
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Targeted photodynamic therapy using reconstituted high-density lipoproteins as rhodamine transporters.
Ávila-Sánchez MA, Isaac-Olivé K, Aranda-Lara L, Morales-Ávila E, Plata-Becerril A, Jiménez-Mancilla NP, Ocampo-García B, Estrada JA, Santos-Cuevas CL, Torres-García E, Camacho-López MA. Ávila-Sánchez MA, et al. Among authors: jimenez mancilla np. Photodiagnosis Photodyn Ther. 2022 Mar;37:102630. doi: 10.1016/j.pdpdt.2021.102630. Epub 2021 Nov 17. Photodiagnosis Photodyn Ther. 2022. PMID: 34798347
Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image.
Luna-Gutiérrez M, Ocampo-García B, Jiménez-Mancilla N, Ancira-Cortez A, Trujillo-Benítez D, Hernández-Jiménez T, Ramírez-Nava G, Hernández-Ramírez R, Santos-Cuevas C, Ferro-Flores G. Luna-Gutiérrez M, et al. Among authors: jimenez mancilla n. Pharmaceutics. 2022 Mar 27;14(4):720. doi: 10.3390/pharmaceutics14040720. Pharmaceutics. 2022. PMID: 35456554 Free PMC article.
225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins.
Ocampo-García B, Cruz-Nova P, Jiménez-Mancilla N, Luna-Gutiérrez M, Oros-Pantoja R, Lara-Almazán N, Pérez-Velasco D, Santos-Cuevas C, Ferro-Flores G. Ocampo-García B, et al. Among authors: jimenez mancilla n. Int J Mol Sci. 2023 Nov 21;24(23):16553. doi: 10.3390/ijms242316553. Int J Mol Sci. 2023. PMID: 38068876 Free PMC article.
Clinical translation of a PSMA inhibitor for 99mTc-based SPECT.
Ferro-Flores G, Luna-Gutiérrez M, Ocampo-García B, Santos-Cuevas C, Azorín-Vega E, Jiménez-Mancilla N, Orocio-Rodríguez E, Davanzo J, García-Pérez FO. Ferro-Flores G, et al. Among authors: jimenez mancilla n. Nucl Med Biol. 2017 May;48:36-44. doi: 10.1016/j.nucmedbio.2017.01.012. Epub 2017 Feb 3. Nucl Med Biol. 2017. PMID: 28193503
99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe.
Ferro-Flores G, Ocampo-García B, Cruz-Nova P, Luna-Gutiérrez M, Bravo-Villegas G, Azorín-Vega E, Jiménez-Mancilla N, Michel-Sánchez E, García-Pérez O, Lara-Almazán N, Santos-Cuevas C. Ferro-Flores G, et al. Among authors: jimenez mancilla n. Pharmaceutics. 2023 Nov 23;15(12):2662. doi: 10.3390/pharmaceutics15122662. Pharmaceutics. 2023. PMID: 38140003 Free PMC article.
Preparation and Dosimetry Assessment of 166Dy₂O₃/166Ho₂O₃-iPSMA Nanoparticles for Targeted Hepatocarcinoma Radiotherapy.
Canseco-Hernández O, Ferro-Flores G, Jimenez-Mancilla N, Aranda-Lara L, Ocampo-Garcia B, Trujillo-Benitez D, Ancira-Cortés A, Morales-Avila E, Santos-Cuevas C. Canseco-Hernández O, et al. Among authors: jimenez mancilla n. J Nanosci Nanotechnol. 2021 Nov 1;21(11):5449-5458. doi: 10.1166/jnn.2021.19455. J Nanosci Nanotechnol. 2021. PMID: 33980355
177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer.
Santos-Cuevas C, Ferro-Flores G, García-Pérez FO, Jiménez-Mancilla N, Ramírez-Nava G, Ocampo-García B, Luna-Gutiérrez M, Azorín-Vega E, Davanzo J, Soldevilla-Gallardo I. Santos-Cuevas C, et al. Among authors: jimenez mancilla n. Contrast Media Mol Imaging. 2018 Nov 11;2018:5247153. doi: 10.1155/2018/5247153. eCollection 2018. Contrast Media Mol Imaging. 2018. PMID: 30534027 Free PMC article.
Synthesis and evaluation of Lys¹(α,γ-Folate)Lys³(¹⁷⁷Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer.
Aranda-Lara L, Ferro-Flores G, Azorín-Vega E, Ramírez FM, Jiménez-Mancilla N, Ocampo-García B, Santos-Cuevas C, Isaac-Olivé K. Aranda-Lara L, et al. Among authors: jimenez mancilla n. Appl Radiat Isot. 2016 Jan;107:214-219. doi: 10.1016/j.apradiso.2015.10.030. Epub 2015 Oct 28. Appl Radiat Isot. 2016. PMID: 26545016
Synthesis and Evaluation of 177Lu-DOTA-PD-L1-i and 225Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy.
Luna-Gutiérrez M, Cruz-Nova P, Jiménez-Mancilla N, Oros-Pantoja R, Lara-Almazán N, Santos-Cuevas C, Azorín-Vega E, Ocampo-García B, Ferro-Flores G. Luna-Gutiérrez M, et al. Among authors: jimenez mancilla n. Int J Mol Sci. 2023 Aug 3;24(15):12382. doi: 10.3390/ijms241512382. Int J Mol Sci. 2023. PMID: 37569758 Free PMC article.
24 results